Effect of Electric Charge on Biotherapeutic Transport, Binding and Absorption: A Computational Study

Mario de Lucio ∗, Pavlos P. Vlachos, Hector Gomez · 2026

Read Effect of Electric Charge on Biotherapeutic Transport, Binding and Absorption: A Computational Study by Mario de Lucio ∗, Pavlos P. Vlachos, Hector Gomez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2601-00505.txt.

Introduction

Mario de Lucio, Pavlos Vlachos, and Hector Gomez model how electric charge affects the fate of antibody drugs injected under the skin. Monoclonal antibodies are large protein medicines, and after a subcutaneous injection they must travel through tissue, bind their targets, and enter circulation. Charge shapes each of those steps, yet it is hard to observe directly.

The authors build a mathematical and computational model grounded in the Nernst-Planck equations and porous media flow, following two antibodies with different electric properties. They vary buffer acidity, body mass index, injection depth, and drug concentration, then compare the simulations with published experimental data. The study maps how formulation and patient factors steer short-term transport and longer-term binding and absorption.

Catalog record

CREATORMario de Lucio ∗, Pavlos P. Vlachos, Hector Gomez
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2601-00505

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Effect of Electric Charge on Biotherapeutic Transport, Binding and Absorption: A Computational Study Mario de Lucio ∗, Pavlos P. Vlachos, Hector Gomez Abstract This study explores the effects of electric charge on the dynamics of drug transport and absorption in subcutaneous injections of monoclonal antibodies (mAbs). We develop a novel mathematical and computational model, based on the Nernst-Planck equations and porous media flow theory, to investigate the complex interactions between mAbs and charged species in subcutaneous tissue. The model enables us to study short-term transport dynamics and long-term binding and absorption for two mAbs with different electric properties. We examine the influence of buffer pH, body mass index, injection depth, and formulation concentration on drug distribution and compare our numerical results with experimental data from the literature. 1 Introduction Subcutaneous injections of monoclonal antibodies (mAbs) have revolutionized modern medicine, becoming a cornerstone in the treatment of various diseases, including cancer and autoimmune disorders. The efficiency of these therapies is governed by complex mechanical, chemical, and electric interactions regulating drug biotransport and bioabsorption in subcutaneous tissues. Fig. 1 shows a schematic illustration of drug administration via subcutaneous injection, where mAbs are delivered into the interstitial area underneath the dermis, commonly referred to as the adipose layer. The interstitium is composed of an extracellular matrix (ECM) made up of collagen, negatively charged glycosaminoglycans (GAGs), and ions [ 49 , 58 ] . The ionic composition of the interstitial fluid (ISF) is presented in Table 1 , with sodium Na + and chloride Cl - comprising 91% of the total ions. mAbs possess ionizable acidic and basic groups, which can lead to a net positive or negative charge depending on the surrounding environment [ 3 ] . This charge influences their interstitial transport through electrostatic interactions with the negatively charged ECM and the ionic species, thereby impacting binding, absorption, and bioavailability [ 35 ] . Positively charged mAbs exhibit increased binding to the ECM, potentially reducing absorption [ 34 ] . Positive charge also promotes cellular uptake, and increased blood clearance [ 31 , 6 ] . The buffer pH used in mAb formulations plays a crucial role in determining the net charge and binding kinetics of the antibodies, which directly influences their interaction with the ECM and ionic species in the interstitial space [ 26 ] . When the buffer solution is injected, it may alter the local tissue pH, which in turn affects the charge of the mAb and its binding kinetics. At lower buffer pH, mAbs may become more positively charged, leading to enhanced binding to the ECM but potentially reducing systemic absorption due to increased tissue retention. Conversely, higher buffer pH can result in a more negatively charged mAb, reducing ECM binding and improving transport and absorption [ 25 , 23 ] . Thus, studying the effect of buffer pH is crucial for understanding local tissue interactions and drug distribution. Pharmacokinetic/pharmacodynamic (PKPD) models have been widely used to describe mAb distribution and clearance, and some models account for the effect of charge on drug absorption [ 30 , 37 ] . However, these models generally do not capture spatial variations in the tissue, as they are based on ordinary differential equations (ODEs). On the other hand, biomechanical models based on partial differential equations (PDEs) have been developed to incorporate both spatial and temporal distributions of mAbs in tissue, allowing for a more accurate representation of drug transport and absorption. Many of these models are based on a coupling of a poroelastic material framework [ 10 , 29 , 14 ] with drug transport dynamics [ 15 , 13 ] , and some extend this approach to include more complex constitutive material models, such as porohypereslatic [ 28 , 11 , 12 ] , or even poroviscoelastic [ 27 , 4 ] . Additionally, other researchers have utilized multicompartment models, which explicitly account for fluid exchanges between the blood, interstitium, and lymphatic vessels, offering a more comprehensive understanding of mAb transport and distribution [ 56 , 57 , 55 ] . However, these models often omit the role of charge, focusing primarily on fluid flow, diffusion, and tissue mechanics. In this work, we develop a multiphysics computational model to investigate the effect of electric charge on mAb transport, binding, and absorption during subcutaneous injection. The model incorporates three main mechanisms: advection, driven by porous media flow, diffusion and electromigration. We account for the pH-dependency of the drug charge and binding kinetics. We apply this model to study transport and binding phenomena across various buffer pH levels, body mass indices and injection depths. Figure 1: Schematic illustration of the injection process at different scales. Monoclonal antibodies (mAbs) carry an electric charge that varies with the pH level. Upon injection into the adipose layer, mAbs interact with the ion species within the extracellular matrix (ECM) of the tissue, which in turn modifies the local electric potential \Phi and pH. These changes influence the binding rate of mAbs to the ECM. Table 1: Ionic composition of Interstitial Fluid (ISF). Extracted from [ 43 ] . Species ISF Na + 146 mM K + 4.1 mM Cl - 118 mM HCO {}_{3}^{-} 22.0 mM H + pH=7.44 2 Governing equations The core of our computational framework lies in the Nernst-Planck equations [ 46 , 5 ] . These equations describe the diffusion and electromigration of ionic species within a medium, considering both the influence of concentration gradients and the electric potential. In our model, the Nernst-Planck equations are coupled with a porous media flow model based on Darcy’s law. This set of equations provides the framework to comprehend the interplay between charged species during subcutaneous injections of mAbs. In this model, the mass conservation of each ion species can be written as \frac{\partial\left(c_{i}n\right)}{\partial t}+\nabla\cdot\bm{j}_{i}=q_{i}, (1) where c_{i} is the molar concentration of each ion species, n is the porosity of the medium, which we assume is constant, t is time, q_{i} is a reactive sink/source term, and \bm{j}_{i} is the mass flux vector \bm{j}_{i}=\underbrace{\bm{u}c_{i}}_{\text{Advection}}-\underbrace{D_{i}n\nabla c_{i}}_{\text{Diffusion}}-\underbrace{z_{i}\frac{D_{i}F}{RT}nc_{i}\nabla\Phi}_{\text{Electromigration}}\qquad\text{ (no sum on $i$) }. (2) Here, \bm{u} is the fluid velocity, D_{i} is the diffusion coefficient of the i -th species, z_{i} is the ionic valence, F is the Faraday constant, R is the universal gas constant, T is the temperature, and \Phi is the electric potential. We model fluid flow using Darcy’s law, and assuming that the fluid is incompressible, \bm{u}=-\frac{\kappa}{\eta}\nabla p,\text{ with }\nabla\cdot\bm{u}=q_{p}+J_{b}-J_{l}, (3) where \kappa is the permeability of the porous medium, \eta is the fluid dynamic viscosity, p is the pore pressure, q_{p} is a source term representing the injection of solvent or buffer solution, and J_{b} , J_{l} model the blood filtration and lymphatic uptake, respectively. The electric potential \Phi is an additional unknown scalar field in Eqn. ( 1 ), which is determined from the electroneutrality condition \sum_{i=1}^{m}z_{i}c_{i}=0. (4) This condition is an algebraic constraint originating from the assumption that the electrolyte solution is locally electrically neutral. In a macroscopic model, such as the one we are interested in, Eqn. ( 4 ) provides an adequate and generally accepted approximation. By using the electroneutrality condition, we can eliminate one ionic concentration from the system of equations using c_{m}=-\frac{1}{z_{m}}\sum_{i=1}^{m-1}z_{i}c_{i}, (5) and assuming z_{m}\neq

Read the complete text